Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Omalizumab reported to be as safe as placebo in allergic asthma/rhinitis

Nov. 18, 2002

Cost savings reported in COPD patients treated with cilomilast

Nov. 18, 2002

Chest 2002: imatinib mesilate in pulmonary fibrosis

Nov. 18, 2002

Symptom relief achieved with tiotropium in mild COPD

Nov. 15, 2002

Zileuton reported to improve airways inflammation in cystic fibrosis

Nov. 15, 2002

Altana Pharma claims novel series of tryptase inhibitors with utility in airways disorders

Nov. 15, 2002

Series of integrin antagonists for asthma and other disorders prepared at Merck & Co.

Nov. 14, 2002

Safety study completed for inhaled form of epinephrine

Nov. 13, 2002

Altana researchers identify novel tryptase inhibitors for asthma and other respiratory disorders

Nov. 13, 2002

Cetirizine approved for pediatric use

Nov. 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...